Treatment of the cardiovascular manifestations of phosphine poisoning with trimetazidine, a new antiischemic drug [11]

American Journal of Emergency Medicine

Volumn 17, Issue 2, 1999, Pages 219-220

  Duenas, A ^a   Perez Castrillon, J L ^a   Cobos, M A ^a   Herreros, V ^a  

^a HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM PHOSPHIDE; MAGNESIUM SULFATE; TRIMETAZIDINE;

CARDIOTOXICITY; CLINICAL FEATURE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ELECTROCARDIOGRAPHY MONITORING; GASTROINTESTINAL SYMPTOM; HEART VENTRICLE EXTRASYSTOLE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; OCCUPATIONAL TOXICOLOGY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0032998997     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-6757(99)90075-X     Document Type: Letter

References (5)

1. R Wilson F Lovejoy R Jaeger P Landrigan Acute phosphine poisoning aboard a grain freighter Epidemiologic, clinical and pathological findings JAMA 244 1980 148 150
2. S Sing JB Dilawari R Vashist Aluminium phosphide ingestion BMJ 290 1985 1110 1111
3. SB Lall K Sinha S Mittra SD Seth An experimental study on cardiotoxicity of aluminium phosphide Indian J Exp Biol 35 1997 1060 1064
4. SN Chugh T Kolley R Kakkar A critical evaluation of anti-peroxidant effect of intravenous magnesium in acute aluminium phosphide poisoning Magnes Res 10 1997 225 230
5. J Leiris F Boucher Rationale for trimetazidine administration in myocardial ischaemia-reperfusion syndrome Eur Heart J 14 S-G 1993 34 40